期刊文献+

CAR-T细胞治疗产品体外效力的检测策略与技术进展

Review of in vitro potenc assays for CAR-T cell therapy products
原文传递
导出
摘要 随着嵌合抗原受体T细胞(chimeric antigen receptor T cell, CAR-T)等细胞治疗产品的应用走向成熟,其产品质量的检测方法也日渐受到关注。体外活力是评价细胞治疗产品有效性的重要方法,体外效力测定方法也以其简单、快速的特点,在产品放行过程中被广泛采用。本文从效应细胞及靶细胞这2个角度对CAR-T等细胞治疗产品体外效力测定方法进行综述。 As the use of cell therapy products such as chimeric antigen receptor T cells(CAR-T)is getting matured,there has been an increasing interest in the methods used to test the quality of cell therapy products.In vitro viability assay is an important method for evaluating the effectiveness of cell therapy products and is also widely used in the product release process because of its simplicity and rapidity.In this paper,we review the in vitro potency determination methods for cell therapy products such as CAR-T from the perspective of both effector cells and target cells.
作者 王自强 王灿 厉高慜 段徐华 邵泓 WANG Zi-qiang;WANG Can;LI Gao-min;DUAN Xu-hua;SHAO Hong(Shanghai Institute for Food and Drug Control/National Medical Products Administration Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies/Shanghai Quality Inspection and Testing Center for Innovative Biological Products,Shanghai 201203,China)
出处 《中国新药杂志》 CAS CSCD 北大核心 2023年第18期1837-1842,共6页 Chinese Journal of New Drugs
关键词 CAR-T细胞 效力测定 质量控制 细胞杀伤 细胞因子分泌 CAR-T cells potency assay quality control cell killing cytokine secretion
  • 相关文献

参考文献14

二级参考文献64

  • 1李传保,王建中,吴煦,袁家颖,汪润,张爱玉,赵燕君,屈晨雪,王新华.流式微球技术检测血小板微粒的方法建立及其评价[J].中华医学杂志,2005,85(23):1629-1632. 被引量:5
  • 2凌焱,段海清,陈惠鹏.合成生物学[J].军事医学科学院院刊,2006,30(6):572-574. 被引量:13
  • 3Nishimura R,Hata K,Yoneda T.Differentiation of bone marrow stroma-derived mesenchymal cells[J].Curr Med Chem,2007,14(2):173-179.
  • 4Blanc KL,Tammik L,Sundberg B,et al.Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex[J].Scand.J.Immunol,2003,57:11-20.
  • 5Krampera M,Glennie S,Dyson J,et al.Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide[J].Blood,2003,101:3722-3729.
  • 6Rasmusson I.Immune modulation by mesenchymal stem cells[J].Exp Cell Res,2006,312:2169-2179.
  • 7Binder CJ,Chang MK,Shaw PX,et al.Innate and acquired immunity in atherogenesis[J].Nat Med,2002,8:1218-1226.
  • 8de Boer OJ,Hirsch F,van der Wal AC,et al.Costimulatory molecules in human atherosclerosis plaques:an indication of antigen specific T lymphocyte activation[J].Atherosclerosis,1997,133:227-234.
  • 9Zhou X,Paulsson G,Stemme S,et al.Hypercholesterolemia is associated with a T helper(Th)1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice[J].J Clin Invest 1998,101:1717-1725.
  • 10Yu S,Chen Z,Quezada HC.et al.Increase suscepetibility to experimental auto immune nerristis afer upregulation of the autoreactive T cell response to peripheralmyelit antigen in apolipoprotein E-deficient mice[J].J Neuropathol.Exp Neurol,2004,63:120-128.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部